This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Pharmacotherapy of Panic Disorder: Differential Efficacy From a Clinical Viewpoint

Johan A. den Boer, M.D., Ph.D.

Published: June 1, 1998

Article Abstract

Antidepressants and high-potency benzodiazepines have been used to treat patients with panic disorder.This review considers the efficacy of these treatments in reducing panic attack frequency and inaddition considers their ability to attenuate global anxiety, depressive symptomatology, agoraphobicavoidance, and overall impairment. An extensive database is available for the tricyclic antidepressantsimipramine and clomipramine, the serotonin selective reuptake inhibitor paroxetine, and the benzodiazepinealprazolam. The antidepressants are more effective than the benzodiazepines in reducing associateddepressive symptomatology and are at least as effective for improving anxiety, agoraphobia,and overall impairment.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: